Thyroid cancer is the most common endocrine malignancy, with over 43,000 new cases diagnosed in the United States each year. The good news: most thyroid cancers are highly treatable, with excellent long-term outcomes for the most common types.

Types of Thyroid Cancer

  • Papillary thyroid cancer (PTC) ā€” The most common type, accounting for ~85% of cases. It tends to grow slowly and is usually curable with surgery. It spreads to lymph nodes in the neck but has an excellent prognosis.
  • Follicular thyroid cancer ā€” Accounts for ~10% of cases. More likely to spread via the bloodstream to distant organs (lungs, bone). Generally has good outcomes when caught early.
  • Medullary thyroid cancer (MTC) ā€” Arises from C-cells of the thyroid that produce calcitonin. Can be sporadic or hereditary (as part of MEN2 syndrome). Genetic testing is important.
  • Anaplastic thyroid cancer ā€” Rare (~1ā€“2%) but very aggressive; requires rapid multidisciplinary treatment.

šŸ“Š Prognosis: The 10-year survival rate for papillary and follicular thyroid cancer is over 95% when diagnosed early. Thyroid cancer is among the most curable of all cancers.

Risk Factors

  • Female sex (3:1 female-to-male ratio)
  • Age (peak incidence in 30sā€“50s for women; older for men)
  • Radiation exposure to the head and neck, especially in childhood
  • Family history of thyroid cancer
  • Hereditary syndromes (MEN2, familial papillary thyroid cancer, Cowden syndrome)
  • Iodine deficiency (associated with follicular type)

Symptoms and Diagnosis

Thyroid cancer often presents as a thyroid nodule discovered incidentally or during routine examination. Symptoms suggesting malignancy may include rapid growth of a nodule, hoarseness, difficulty swallowing, or enlarged neck lymph nodes. Fine needle aspiration (FNA) biopsy is the primary diagnostic tool, supplemented by ultrasound and, when needed, molecular testing.

Treatment

Surgery is the mainstay of treatment for most thyroid cancers. The extent of surgery (lobectomy vs. total thyroidectomy) depends on the cancer type, size, and risk features. After surgery:

  • Radioactive iodine (RAI) ablation may be used in higher-risk cases to destroy any remaining thyroid tissue and treat potential metastases
  • TSH suppression therapy with levothyroxine is used to keep TSH low and reduce stimulation of any residual cancer cells
  • External beam radiation or targeted therapies may be used for aggressive or metastatic disease

Surveillance After Treatment

Long-term follow-up is essential. This includes regular neck ultrasound, thyroglobulin (Tg) blood tests (a tumor marker), and periodic TSH/free T4 monitoring. An endocrinologist plays a central role in long-term thyroid cancer surveillance and management of thyroid hormone replacement after thyroidectomy.

Key Takeaways

  • Thyroid cancer is very common but also among the most curable of all cancers
  • Papillary thyroid cancer is the most common type with excellent outcomes
  • Treatment usually involves surgery, sometimes followed by radioactive iodine
  • Lifelong thyroid hormone replacement and surveillance are needed after thyroidectomy
  • An endocrinologist is essential for long-term post-treatment management
Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making any changes to your treatment plan. Individual medical decisions should be made in partnership with your physician based on your specific circumstances.